SG11201704397VA - Piperidine substituted pyrazolo[1,5-a]pyrimidine derivatives with inhibitory activity on the replication of the respiratory syncytial virus (rsv) - Google Patents
Piperidine substituted pyrazolo[1,5-a]pyrimidine derivatives with inhibitory activity on the replication of the respiratory syncytial virus (rsv)Info
- Publication number
- SG11201704397VA SG11201704397VA SG11201704397VA SG11201704397VA SG11201704397VA SG 11201704397V A SG11201704397V A SG 11201704397VA SG 11201704397V A SG11201704397V A SG 11201704397VA SG 11201704397V A SG11201704397V A SG 11201704397VA SG 11201704397V A SG11201704397V A SG 11201704397VA
- Authority
- SG
- Singapore
- Prior art keywords
- rsv
- replication
- inhibitory activity
- respiratory syncytial
- syncytial virus
- Prior art date
Links
- 241000725643 Respiratory syncytial virus Species 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 125000003386 piperidinyl group Chemical group 0.000 title 1
- LDIJKUBTLZTFRG-UHFFFAOYSA-N pyrazolo[1,5-a]pyrimidine Chemical class N1=CC=CN2N=CC=C21 LDIJKUBTLZTFRG-UHFFFAOYSA-N 0.000 title 1
- 230000010076 replication Effects 0.000 title 1
- NQRYJNQNLNOLGT-UHFFFAOYSA-N tetrahydropyridine hydrochloride Natural products C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14196782 | 2014-12-08 | ||
| PCT/EP2015/078762 WO2016091774A1 (en) | 2014-12-08 | 2015-12-07 | Piperidine substituted pyrazolo[1,5-a]pyrimidine derivatives with inhibitory activity on the replication of the respiratory syncytial virus (rsv) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201704397VA true SG11201704397VA (en) | 2017-06-29 |
Family
ID=52006929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201704397VA SG11201704397VA (en) | 2014-12-08 | 2015-12-07 | Piperidine substituted pyrazolo[1,5-a]pyrimidine derivatives with inhibitory activity on the replication of the respiratory syncytial virus (rsv) |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9981976B2 (en) |
| EP (1) | EP3230287B1 (en) |
| JP (2) | JP2017537118A (en) |
| KR (1) | KR102522832B1 (en) |
| CN (1) | CN107001377B (en) |
| AU (1) | AU2015359624B2 (en) |
| CA (1) | CA2963051C (en) |
| EA (1) | EA032081B1 (en) |
| ES (1) | ES2704740T3 (en) |
| MX (1) | MX368162B (en) |
| SG (1) | SG11201704397VA (en) |
| WO (1) | WO2016091774A1 (en) |
| ZA (1) | ZA201703899B (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107207512B (en) | 2014-12-08 | 2019-09-10 | 爱尔兰詹森科学公司 | Tricyclic pyrazole simultaneously [1, the 5-A] pyrimidine derivatives that there is the piperidines of inhibitory activity to replace the duplication of Respiratory Syncytial Virus(RSV) (RSV) |
| JO3637B1 (en) | 2015-04-28 | 2020-08-27 | Janssen Sciences Ireland Uc | Rsv antiviral pyrazolo- and triazolo-pyrimidine compounds |
| TW201932470A (en) | 2017-11-29 | 2019-08-16 | 愛爾蘭商健生科學愛爾蘭無限公司 | Pyrazolopyrimidines having activity against RSV |
| JP7305658B2 (en) * | 2018-01-31 | 2023-07-10 | ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー | Cycloalkyl-substituted pyrazolopyrimidines with anti-RSV activity |
| WO2019206828A1 (en) | 2018-04-23 | 2019-10-31 | Janssen Sciences Ireland Unlimited Company | Heteroaromatic compounds having activity against rsv |
| KR20210074312A (en) * | 2018-10-10 | 2021-06-21 | 큐로비르 아베 | 2,6-dimethyl-N-((pyridin-4-yl)methyl)imidazole[1,2-b]pyridazin-8-amine and 2,5-dimethyl-N for the treatment of viral infections -[(pyridin-4-yl)methyl]pyrazolo[1,5-a]pyrimidin-7-amine derivative |
| MX2021006138A (en) * | 2018-11-26 | 2021-06-23 | Janssen Sciences Ireland Unlimited Co | Further heteroaromatic compounds having activity against rsv. |
| WO2020138015A1 (en) | 2018-12-27 | 2020-07-02 | 大正製薬株式会社 | Pyrazolo[1,5-a]pyrimidine macrocyclic compound |
| AU2020214064B2 (en) * | 2019-01-29 | 2022-10-20 | Shandong Xuanzhu Pharma Co., Ltd. | Hexone glucokinase inhibitor and use thereof |
| WO2021129737A1 (en) * | 2019-12-24 | 2021-07-01 | 南京明德新药研发有限公司 | Compound having khk inhibitory effect |
| WO2021215765A1 (en) * | 2020-04-20 | 2021-10-28 | 주식회사 엘지화학 | 3-azabicycloalkyl derivative and pharmaceutical composition containing same |
| CN113754640B (en) * | 2020-06-03 | 2023-02-14 | 山东轩竹医药科技有限公司 | Deuterated ketohexokinase inhibitors and uses thereof |
| CN112724157B (en) * | 2021-01-23 | 2022-04-19 | 中国科学院新疆理化技术研究所 | Dihydrooxazolo [5,4-d ] pyrrolo [1,2-a ] pyrimidin-9 (5H) -one derivatives and use thereof |
| AU2022296214A1 (en) * | 2021-06-25 | 2024-01-25 | Albius Sciences Alpha Private Limited | Heterocycloalkyl-substituted polyheteroazole derivative as medical drug for treatment and/or prevention of rs virus infectious disease |
| EP4387449A1 (en) | 2021-08-19 | 2024-06-26 | Syngenta Crop Protection AG | Method for controlling diamide resistant pests & compounds therefor |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4192250B2 (en) * | 1997-02-14 | 2008-12-10 | 株式会社ポーラファルマ | Medicine for treatment and prevention of respiratory diseases |
| ES2287476T3 (en) * | 2002-05-10 | 2007-12-16 | Smithkline Beecham Corporation | REPLACED PIRAZOLOPIRIMIDINAS. |
| WO2005030773A1 (en) * | 2003-09-26 | 2005-04-07 | Dainippon Sumitomo Pharma Co., Ltd. | Novel pyrazolopyrimidine derivatives |
| GB0327319D0 (en) * | 2003-11-24 | 2003-12-24 | Pfizer Ltd | Novel pharmaceuticals |
| SG10201505022WA (en) | 2010-06-24 | 2015-07-30 | Gilead Sciences Inc | Pyrazolo [1, 5 -a] pyrimidines as antiviral agents |
| AU2012358805B2 (en) | 2011-12-22 | 2017-07-20 | Gilead Sciences, Inc. | Pyrazolo[1,5-a]pyrimidines as antiviral agents |
| DK2838900T3 (en) * | 2012-04-17 | 2019-10-14 | Gilead Sciences Inc | RELATIONS AND PROCEDURES FOR ANTIVIRAL TREATMENT |
| CN107207512B (en) | 2014-12-08 | 2019-09-10 | 爱尔兰詹森科学公司 | Tricyclic pyrazole simultaneously [1, the 5-A] pyrimidine derivatives that there is the piperidines of inhibitory activity to replace the duplication of Respiratory Syncytial Virus(RSV) (RSV) |
-
2015
- 2015-12-07 WO PCT/EP2015/078762 patent/WO2016091774A1/en active Application Filing
- 2015-12-07 MX MX2017007429A patent/MX368162B/en active IP Right Grant
- 2015-12-07 CA CA2963051A patent/CA2963051C/en active Active
- 2015-12-07 CN CN201580066594.9A patent/CN107001377B/en active Active
- 2015-12-07 AU AU2015359624A patent/AU2015359624B2/en active Active
- 2015-12-07 ES ES15804823T patent/ES2704740T3/en active Active
- 2015-12-07 US US15/534,442 patent/US9981976B2/en active Active
- 2015-12-07 JP JP2017530292A patent/JP2017537118A/en not_active Withdrawn
- 2015-12-07 EA EA201791274A patent/EA032081B1/en not_active IP Right Cessation
- 2015-12-07 EP EP15804823.1A patent/EP3230287B1/en active Active
- 2015-12-07 KR KR1020177014525A patent/KR102522832B1/en active IP Right Grant
- 2015-12-07 SG SG11201704397VA patent/SG11201704397VA/en unknown
-
2017
- 2017-06-07 ZA ZA2017/03899A patent/ZA201703899B/en unknown
-
2019
- 2019-10-01 JP JP2019181463A patent/JP6628930B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US9981976B2 (en) | 2018-05-29 |
| CA2963051A1 (en) | 2016-06-16 |
| EA201791274A1 (en) | 2017-10-31 |
| EP3230287B1 (en) | 2018-10-10 |
| EA032081B1 (en) | 2019-04-30 |
| KR20170090424A (en) | 2017-08-07 |
| CA2963051C (en) | 2023-10-17 |
| MX368162B (en) | 2019-09-20 |
| US20170349591A1 (en) | 2017-12-07 |
| AU2015359624B2 (en) | 2020-01-02 |
| MX2017007429A (en) | 2017-09-28 |
| ZA201703899B (en) | 2019-01-30 |
| KR102522832B1 (en) | 2023-04-17 |
| CN107001377B (en) | 2019-09-10 |
| CN107001377A (en) | 2017-08-01 |
| AU2015359624A1 (en) | 2017-04-13 |
| JP6628930B1 (en) | 2020-01-15 |
| JP2017537118A (en) | 2017-12-14 |
| JP2020011991A (en) | 2020-01-23 |
| WO2016091774A1 (en) | 2016-06-16 |
| EP3230287A1 (en) | 2017-10-18 |
| ES2704740T3 (en) | 2019-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201703899B (en) | Piperidine substituted pyrazolo[1,5-a]pyrimidine derivatives with inhibitory activity on the replication of the respiratory syncytial virus (rsv) | |
| IL266170A (en) | Process for the preparation of pyrazolo[1,5-a]pyrimidines and salts thereof | |
| HK1257146A1 (en) | Novel pyrazolo[3,4-d]pyrimidine compound or salt thereof | |
| HK1249502A1 (en) | Pyrido(3,4-d) pyrimidine derivative and pharmaceutically acceptable salt thereof | |
| EP3268000A4 (en) | Pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives as cdk inhibitors | |
| HK1258157A1 (en) | Pyrazolo[1,5-a]pyrazin-4-yl derivatives as jak-inhibitors | |
| SI3030563T1 (en) | Pyrrolo (3,2-d) pyrimidine derivatives for the treatment of viral infections and other diseases | |
| EP3173412A4 (en) | 2,4-disubstituted 7h-pyrrolo[2,3-d]pyrimidine derivative, preparation method and medicinal use thereof | |
| EP3096762C0 (en) | Pyrazolo[1,5-a]pyrimidines as antiviral compounds | |
| IL262673A (en) | Pyrazolo[1,5-a]pyrimidine compound | |
| ZA201902893B (en) | Pyrido[3, 4-d]pyrimidine derivative and pharmaceutically acceptable salt thereof | |
| ZA201703900B (en) | Piperidine substituted tricyclic pyrazolo[1,5-a]pyrimidine derivatives with inhibitory activity on the replication of the respiratory syncytial virus (rsv) | |
| EP3235816A4 (en) | 2-morpholin-4,6-disubstituted pyrimidine derivative, and preparation method and pharmaceutical use thereof | |
| IL274898A (en) | Pyrazolopyrimidines having activity against the respiratory syncytial virus (rsv) | |
| EP3287459A4 (en) | Purinyl-n-hydroxyl pyrimidine formamide derivatives, preparation method therefor and use thereof | |
| HUE050298T2 (en) | Pyrazolo[3,4-d]pyrimidine compounds or salts thereof | |
| TH1501007495A (en) | Pyrrolo[3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases. | |
| TH1601001194A (en) | New triazolo[4,5-d]pyrimidine derivatives |